Key stats
About First Trust NYSE Arca Biotechnology ETF Trust Units
Home page
Inception date
Feb 17, 2021
Structure
Canadian Mutual Fund Trust (ON)
Dividend treatment
Distributes
Primary advisor
FT Portfolios Canada Co.
ISIN
CA33742D1050
The fund provides exposure to biotech companies involved in the use of biological processes to develop products or provide services. The underlying index contains 30 names, an increase from 20 in October 2014. Without a specific sector classification scheme, the funds broad exposure could include access to pharmaceuticals and medical technology in addition to traditional biotech. Still, FBTs equal weighting of about 30 stocks produces a relatively concentrated basket. The index is reconstituted and rebalanced quarterly.
Related funds
Classification
What's in the fund
Exposure type
ETF
Stock breakdown by region
Top 10 holdings
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
FBT trades at 36.76 CAD today, its price has risen 2.57% in the past 24 hours. Track more dynamics on FBT price chart.
FBT net asset value is 35.85 today — it's risen 8.10% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.
FBT assets under management is 2.14 M CAD. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
FBT price has risen by 10.82% over the last month, and its yearly performance shows a 27.11% increase. See more dynamics on FBT price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 8.10% over the last month, showed a 18.29% increase in three-month performance and has increased by 26.03% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 8.10% over the last month, showed a 18.29% increase in three-month performance and has increased by 26.03% in a year.
FBT fund flows account for 314.96 K CAD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
FBT invests in funds. See more details in our Analysis section.
FBT expense ratio is 0.73%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, FBT isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, FBT technical analysis shows the strong buy rating and its 1-week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating FBT shows the strong buy signal. See more of FBT technicals for a more comprehensive analysis.
Today, FBT technical analysis shows the strong buy rating and its 1-week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating FBT shows the strong buy signal. See more of FBT technicals for a more comprehensive analysis.
FBT trades at a premium (0.02%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
FBT shares are issued by AJM Ventures LLC
FBT follows the NYSE Arca Biotechnology Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Feb 17, 2021.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.